Safety and efficacy of sunitinib for advanced non‐clear cell renal cell carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1743-7563|11|4|328-333

ISSN： 1743-7555

Source： ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol.11, Iss.4, 2015-12, pp. : 328-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sunitinib Treatment for Patients with Advanced Clear-Cell Renal-Cell Carcinoma after Progression on Sorafenib

By  

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 350-354

Karger

Access to resources Recommend Favorite

Sunitinib for Asian Patients with Advanced Renal Cell Carcinoma: A Comparable Efficacy with Different Toxicity Profiles

By  

Oncology, Vol. 80, Iss. 5-6, 2011-08 ,pp. : 395-405

Karger

Access to resources Recommend Favorite

Safety and Efficacy of Sunitinib in Patients from Italy with Metastatic Renal Cell Carcinoma: Final Results from an Expanded-Access Trial

By  

Oncology, Vol. 88, Iss. 5, 2015-01 ,pp. : 273-280

Karger

Access to resources Recommend Favorite

Multifocal Brain Metastases in Clear Cell Renal Cell Carcinoma with Complete Response to Sunitinib

By  

Urologia Internationalis, Vol. 83, Iss. 4, 2009-12 ,pp. : 482-485

Karger

Access to resources Recommend Favorite

Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 2999-3006

John Wiley & Sons Inc

Access to resources Recommend Favorite